Cite

HARVARD Citation

    Bang, Y. et al. (n.d.). 525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028. European journal of cancer. pp. S112-. [Online]. 
  
Back to record